HB0052

· Shanghai Huaota Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HB0052, covering 2025-05-28 to 2025-05-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]